Mirmousa Mousavai, Ramin Khajavi, Mohammadreza Kalaee, Mohammad Karim Rahimi
{"title":"Gum tragacanth-based hemostatic sponge for enhanced hemostasis in dental surgery.","authors":"Mirmousa Mousavai, Ramin Khajavi, Mohammadreza Kalaee, Mohammad Karim Rahimi","doi":"10.1080/10837450.2025.2516238","DOIUrl":null,"url":null,"abstract":"<p><p>Regulating hemorrhage is crucial during dental procedures, particularly surgical interventions where substantial blood loss may occur. Hemostatic sponges are effective instruments for controlling hemorrhage, facilitating hemostasis, preparing the surgical area, and enhancing the healing of injuries. This work aimed to present a novel hemostatic sponge created by integrating antihemorrhagic chemicals with the natural polysaccharide tragacanth. Gum tragacanth (GT) (derived from the species Astragalus gossypinus) was solubilized in water and combined with nanoclay (NC) and tranexamic acid (TXA) at varying doses. Subsequently, they were freeze-dried in cubic silicone molds. Scanning electron micrographs revealed that the incorporation of TXA and NC significantly increased the porosity of the sponges. No evidence of chemical bonding was present in our converted infrared spectra. Prothrombin time (PT), activated partial thromboplastin time (aPTT), and whole blood coagulation index showed improvement with the administration of hemostatics, with TXA demonstrating a more pronounced impact. The cytotoxicity assay of the hemostatic GT exhibited no notable difference from the control sample. The hemostatic GT has demonstrated significant potential for medical applications, particularly in dentistry, and applies to procedures such as endodontics and prosthesis placement.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1-25"},"PeriodicalIF":2.6000,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Development and Technology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10837450.2025.2516238","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Regulating hemorrhage is crucial during dental procedures, particularly surgical interventions where substantial blood loss may occur. Hemostatic sponges are effective instruments for controlling hemorrhage, facilitating hemostasis, preparing the surgical area, and enhancing the healing of injuries. This work aimed to present a novel hemostatic sponge created by integrating antihemorrhagic chemicals with the natural polysaccharide tragacanth. Gum tragacanth (GT) (derived from the species Astragalus gossypinus) was solubilized in water and combined with nanoclay (NC) and tranexamic acid (TXA) at varying doses. Subsequently, they were freeze-dried in cubic silicone molds. Scanning electron micrographs revealed that the incorporation of TXA and NC significantly increased the porosity of the sponges. No evidence of chemical bonding was present in our converted infrared spectra. Prothrombin time (PT), activated partial thromboplastin time (aPTT), and whole blood coagulation index showed improvement with the administration of hemostatics, with TXA demonstrating a more pronounced impact. The cytotoxicity assay of the hemostatic GT exhibited no notable difference from the control sample. The hemostatic GT has demonstrated significant potential for medical applications, particularly in dentistry, and applies to procedures such as endodontics and prosthesis placement.
期刊介绍:
Pharmaceutical Development & Technology publishes research on the design, development, manufacture, and evaluation of conventional and novel drug delivery systems, emphasizing practical solutions and applications to theoretical and research-based problems. The journal aims to publish significant, innovative and original research to advance the frontiers of pharmaceutical development and technology.
Through original articles, reviews (where prior discussion with the EIC is encouraged), short reports, book reviews and technical notes, Pharmaceutical Development & Technology covers aspects such as:
-Preformulation and pharmaceutical formulation studies
-Pharmaceutical materials selection and characterization
-Pharmaceutical process development, engineering, scale-up and industrialisation, and process validation
-QbD in the form a risk assessment and DoE driven approaches
-Design of dosage forms and drug delivery systems
-Emerging pharmaceutical formulation and drug delivery technologies with a focus on personalised therapies
-Drug delivery systems research and quality improvement
-Pharmaceutical regulatory affairs
This journal will not consider for publication manuscripts focusing purely on clinical evaluations, botanicals, or animal models.